Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Grohmann

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|April 20, 2022
Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platformsChristoph Grohmann, Charlene M Magtoto, Joel R Walker, et al.
The EMBO Journal|August 27, 2020
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2Theresa Klemm, Gregor Ebert, Dale J Calleja, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|April 20, 2022
Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platformsChristoph Grohmann, Charlene M Magtoto, Joel R Walker, et al.
The EMBO Journal|August 27, 2020
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2Theresa Klemm, Gregor Ebert, Dale J Calleja, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Pageof 2